Home Featured Page 235

Featured

Latest

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA Funds Psychedelic Therapy for Veterans; AbbVie Paid $900M Upfront for Psychedelic Candidate

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

Q & A with Keeno Ahmed-Jones: Dismantling the Echo Chamber of...

Mindset Pharma Announces Additional Preclinical Results Suggesting Superior Efficacy and Improved...

Tryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary...

Psyence Group and UK Psychedelic CRO Partners to Conduct UK Palliative...

Delix Therapeutics Expands Executive Leadership Team

Horizons ETFs Rebalances World’s First Psychedelics ETF

MYND Life Sciences Provides Corporate Update

Clerkenwell Signs First Multi-million Pound Contract with International Psychedelic Bio-tech Company

Real World Research in Psychedelic Science

PT252 – Joel Lambert – Ibogaine, 5-MeO-DMT, and The Warrior Tradition

1...234235236...301 Page 235 of 301

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA Funds Psychedelic Therapy for Veterans; AbbVie Paid $900M Upfront for Psychedelic Candidate

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

Q & A with Keeno Ahmed-Jones: Dismantling the Echo Chamber of...

Mindset Pharma Announces Additional Preclinical Results Suggesting Superior Efficacy and Improved...

Tryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary...

Psyence Group and UK Psychedelic CRO Partners to Conduct UK Palliative...

Delix Therapeutics Expands Executive Leadership Team

Horizons ETFs Rebalances World’s First Psychedelics ETF

MYND Life Sciences Provides Corporate Update

Clerkenwell Signs First Multi-million Pound Contract with International Psychedelic Bio-tech Company

Real World Research in Psychedelic Science

PT252 – Joel Lambert – Ibogaine, 5-MeO-DMT, and The Warrior Tradition

EDITOR PICKS

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY